Company Short-Term Debts: Calidi Biotherapeutics (CLDI)

Graphic logo of Calidi Bio (CLDI)

Calidi Biotherapeutics (CLDI) developments to combat solid tumors are currently in the testing phase, meaning financial stability relies on investment reserves, which stand at 0.00. This price chart helps track this process. The business relies on creating high-margin, scalable stem cell systems. Additionally, Calidi Biotherapeutics (CLDI) is implementing complex cryogenic transport for the secure delivery of viral agents.

Company Short-Term Loans and Borrowings: calidibio.com (CLDI) for 02/21/2024 - 10/28/2026

CLDI (Calidi Biotherapeutics Inc.): analytical breakdowns and indicator data

- price and consensus price forecast:
Stock Price Calidi Bio|CLDI - Consensus Target
- market capitalization data:
Market Capitalization Calidi Biotherapeutics, Inc.|CLDI - Total Enterprise Value
- book capitalization data:
Net Assets per Single Share Calidi Biotherapeutics|CLDI - Accounting Value of Company|Market Cap to Net Assets Ratio calidibio.com|CLDI - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Calidi Biotherapeutics|CLDI - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Calidi Bio|CLDI - Company Aggregate Debts|Debt to Book Capitalization Ratio Calidi Biotherapeutics, Inc.|CLDI - Company Long-Term Loans and Borrowings|Company Short-Term Debts Calidi Biotherapeutics
Fundamental company valuation:CLDI calidibio.com
Flagship merchandise of Calidi Biotherapeutics

Calidi Biotherapeutics (CLDI) focuses on scaling innovative viral platforms for cancer therapy, which requires significant operating expenses. When analyzing the short-term debt load, an investor must distinguish random technical fluctuations from a systemic increase in liabilities, as filtering out market noise prevents erroneous trades and allows for an objective assessment of the business's financial stability during the implementation of its expansion strategy.

Competitors of Calidi Biotherapeutics (CLDI)

ONC: Company Short-Term Debts|HALO - Company Current Liabilities|Company Short-Term Debts RVMD|AAPG (Ascentage Pharma Corp) - Short-Term Debt|CGON - Company Short-Term Debt|Company Short-Term Loans and Borrowings urogen.com (URGN)|Bicara Therapeutics (BCAX) - Company Current Liabilities|Company Short-Term Loans and Borrowings Personalis Inc (PSNL)|Erasca Corp - Company Short-Term Debts|DCTH - Company Current Liabilities|Y-mAbs Therapeutics - Company Current Liabilities|AURA: Company Short-Term Debts|Company Short-Term Debt candeltx.com CADL|Accuray Inc (ARAY) - Company Short-Term Loans and Borrowings|Company Short-Term Debts SLS (SELLAS Life Sciences Group, Inc.)|Short-Term Debt Actuate Therapeutics Inc|Company Short-Term Debts CTOR (Citius Oncology, Inc.)|Company Current Liabilities tuhurabio.com (HURA)|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Fate Therapeutics Inc - Company Short-Term Debts|WHWK - Company Short-Term Debt|TCRX - Company Short-Term Debt|championsoncology.com - Company Short-Term Debts|XBiotech (XBIT) - Short-Term Debt Volume|Company Short-Term Debts CEL-SCI Corp. (CVM)|Company Short-Term Indebtedness OS Therapies Inc.|RADX (Radiopharm Theranostics) - Company Short-Term Debts|Short-Term Debt Volume artivabio.com ARTV|Company Current Liabilities Adlai Nortye|Company Short-Term Loans and Borrowings verupharma.com VERU|TPST - Company Short-Term Debts|XLO - Company Short-Term Debt|renovarobio.com - Company Short-Term Debts|MURA (Mural Oncology) - Short-Term Debt Volume|Company Short-Term Debt KAPA (Kairos Pharma Limited)|Short-Term Debt OnKure (OKUR)|Company Current Liabilities CytoMed Therapeutics|Amount of Current Liabilities curis.com (CRIS)|Company Short-Term Debts Apollomics|Company Short-Term Loans and Borrowings Tharimmune Corporation THAR|ADVB (Advanced Biomed Corp) - Company Short-Term Debts|GNPX: Short-Term Debt|Company Short-Term Debt Sunshine Biopharma SBFM|Xenetic Biosciences, Inc. (XBIO) - Company Short-Term Loans and Borrowings|SLRX (Salarius) - Company Short-Term Debts|Company Short-Term Debts PPBT|AONC - Company Short-Term Debt|Current Liabilities beigene.com (BGNE)|CKPT: Company Short-Term Debts|ELEV - Short-Term Debt|iCAD Corp - Company Current Liabilities|Ikena Oncology, Inc. (IKNA) - Company Short-Term Debts|NTBL - Company Current Liabilities|Viracta Therapeutics, Inc. (VIRX) - Amount of Current Liabilities|MOR: Company Short-Term Debts|Short-Term Debt Volume NAYA Biosciences Inc|Company Short-Term Debts AAPGV (Ascentage Pharma Group Ltd)